Main menu

Pages

EZH2 Inhibitors Advance β-like Cell Regeneration

EZH2 Inhibitors Advance β-like Cell Regeneration https://ift.tt/Xq6Ao3w EZH2 Inhibitors Advance β-like Cell Regeneration Regardless of age and sex the first casualty of diabetes is the pancreatic β-cell. And while current pharmaceutical options for diabetes treatment help control blood glucose levels they do not prevent, retard or reverse the decline in insulin-secreting β-cells.

Comments

Titles